CHR Blog

The Latest on Fertility Research and Treatment

Posts Tagged ‘IVF’

Should IVF Patients Worry About Increased Breast Cancer Risk?

A new study which linked in vitro fertilization (IVF)with an increased risk for breast cancer has caused some concern among patients who are already undergoing – or are planning to undergo – infertility treatments. However, despite the shocking headlines, experts agree that the study’s findings are pure speculation and should not be a reason for women to avoid these types of treatments.

The Australian study, which was published in the medical journal Fertility and Sterility, found that women who underwent IVF were at a slightly increased risk for breast cancer (2%) during their lifetimes, compared to those who took fertility drugs but did not have IVF (1.7%). However, women who had IVF at a young age (around their 24th birthday) were 56% more likely to develop breast cancer than those of the same age group who did not have IVF.

How Breast Cancer and IVF Are Related

Whether breast cancer and IVF or fertility drugs in general are related has been a subject of discussion for decades because infertile women, in principle, are at increased risk to develop breast cancer. Indeed, pregnancies and breast-feeding newborns has for decades been known to reduce breast cancer risk.

When asking whether IVF increases breast cancer risk, one, therefore has to carefully differentiate between the inherent breast cancer risk an infertile woman brings into IVF treatment and any potential additional risk created by the IVF procedure itself.

How IVF in itself could increase breast cancer risk is unknown, but it has been speculated that such risk may be estrogen-related. When women undergo IVF treatment, they are exposed, for a very short period of time, to high levels of circulating estrogen, a female hormone, which is a known risk factor for some breast cancers. However, to think that such a temporary exposure may increase breast cancer risk appears counterintuitive: Pregnancy, a high estrogen state, exposes women to high estrogen levels for nine months.

Linda Giudice, President-Elect of the American Society of Reproductive Medicine (ASRM), failed to make this point when noting in an ASRM press release that “the development of breast cancer is linked to estrogen exposure and the longer one is exposed, the greater the risk.” She continued: “In an IVF cycle, there is a short, but significant elevation in circulating estrogen, and whether this is linked to the observations found in the study is not clear at this time.”

Above noted study results do not prove a cause-and-effect between estrogen exposure and breast cancer risk after IVF. It is equally possible (and maybe even likely) that the original causes of infertility at such unusually young ages (consider how many women seek infertility treatments already at age 24?), like endometriosis, polycystic ovarian syndrome (PCOS), premature menopause, cancer treatments, etc. may be the real culprits.

The study’s lead author, Louise Stewart is, therefore, likely correct in telling Reuters that she doesn’t “think it’s a huge increased risk [for breast cancer] that you should worry or panic (about).” We only wish she and her co-authors had made that point clearer in their published manuscript. It would have prevented this unnecessary fear-mongering!

Posted by admin

IVF is safer than any other medical treatment

IVF is safer than any other medical treatment   You may have seen the media hype over an Australian study that supposedly showed that “common fertility treatments ( like IVF )  raise the risk of birth defects.”  Although headlines of this type appear to dominate the reports on the Australian study, if you read the study itself, what the researchers found is exactly the opposite: fertility treatments do NOT raise birth defect risk. Babies born after fertility treatments do have a slightly higher rate of birth defects, but it is because of the underlying medical issues involved in the parents’ infertility, NOT due to fertility treatments themselves.

It is rather disappointing to note how little has changed in over 30 years in how the media present the technique of in vitro fertilization (IVF) to the public. When the first IVF baby was born in the UK in May of 1979, some media predicted an epidemic of “monsters.” Ever since, no opportunity has been lost to exaggerate the negative and to ignore the positive of IVF treatment.

With publication of a new study in the May 5, 2012 issue of the New England Journal of Medicine, the pattern continues. In this paper, researchers from Australia, in an effort to offer a long-term outcome control study, did what every drug and medical device manufacturer should do for their medical products (and, unfortunately, only rarely does!): they followed up on the outcome of babies born after IVF treatment. Since the inception of IVF, professionals in this field all over the world have been doing this routinely in innumerable studies, small and big, and have found ABSOLUTELY NO SIGNIFICANT INCREASES IN ABNORMALITIES attributable to IVF procedures!

In contrast to how this study was, unfortunately, once again presented in the media, this Australian study, in essence, reconfirmed this age-old finding. There is absolutely nothing in this study that was not known before, based on many such follow up studies performed on different patient populations (such divergence is important because medical consequences can differ in different populations) all over the world.

It has been known for many years that children born after any form of infertility treatment will demonstrate a small increase in birth defects. However, as the authors of this Australian study also noted in their comments, this increase has repeatedly been shown NOT to be the consequence of IVF itself, but overwhelmingly due to the fact that infertile women and men have underlying medical conditions, which, once they are overcome by IVF, converting an infertile couple into a fertile one, will increase certain parental birth defect risks for the offspring. Probably quantitatively the most significant is the association of an increased risk of urogenital birth defects, mainly in male offspring, after intracytoplasmic sperm injection (ICSI) to overcome severe male infertility.

Not only has CHR informed our patients in our informed consent process about these small risks ever since they became apparent in follow up studies, but CHR physicians have in scientific publications (Gleicher N. Modern obstetrical and infertility care may increase the prevalence of disease: an evolutionary concept. Fertil Steril 2003; 79:249-52) repeatedly pointed out that this principle about “increased risks” to offspring also applies to many medical diseases.

For example, diabetic women until only a few decades ago almost never had children because uncontrolled diabetes usually resulted in infertility or, if women did conceive, resulted in miscarriages. With the advent of insulin therapy, this started to change, and over the last two to three decades the chance of fertility of a diabetic woman is basically the same as that of a non-diabetic female. But the risk of the child of a diabetic woman to become diabetic is, of course, much higher! Moreover, the poorer a diabetic woman’s blood sugar is controlled during the first few weeks of her pregnancy, the higher her risk for birth defects.

The same applies to women with autoimmune diseases and practically all other medical diseases (Gleicher et al., The impact of abnormal autoimmune function on reproduction: maternal and fetal consequences. J Autoimmun 2006;27:161-5).

In an evolutionary sense, infertility can, in many ways, be viewed as nature’s way to prevent inheritance of genetic risks into the next generation. By overcoming infertility, we overcome this nature’s block, and, inadvertently increase certain risks of diseases (and birth defects) for the next generation. Fortunately, these increases in risk are relatively small, because, while genetic in nature, these diseases and defects are usually multifactorial and not related to just one gene. Such multifactorial risks are assumed to be the consequence of multigenetic combinations, in association with environmental factors and usually hover in the single digit range.

We hope that all of these examples point out the media presentation of this most recent IVF paper was, once again, sensationalism at its best. The study, once more, confirmed what now has been known for many years: IVF, in itself, with absolutely minimal exceptions, does not increase risks for birth defects. Having said this, IVF, of course, indirectly, does increase risks to offspring because IVF allows infertile women (and their male partners) with genetic predispositions towards certain risks to become genetic parents, and that automatically means increased risks for their offspring.

After over four million IVF births worldwide, we, however, can state with a high level of confidence that IVF is, likely, much safer a treatment than most other major medical treatments administered about which you never hear in the media. One wonders why!

Category: IVF

Posted by admin

Mini IVF less effective than originally believed

Mini-IVFA new study by CHR casts doubt on the effectiveness of low intensity IVF (LI-IVF) programs, also known as “mini IVF,” “natural IVF” and various other names.

The findings, published in the journal Reproductive Biomedicine Online, revealed that LI-IVF programs, which use lower doses of fertility medications to reduce costs, do not measure up to claims of pregnancy rates comparable to those in conventional IVF.

Many LI-IVF proponents claim that the procedure is more economical and “patient-friendly.” Researchers at CHR decided to evaluate this claim, and matched patients in LI-IVF cycles to comparable patients undergoing traditional IVF cycles. What they found was that patients in LI-IVF cycles produced significantly fewer oocytes and embryos, and demonstrated lower pregnancy rates.

Cost savings with LI-IVF were also unverifiable, as patients took longer to conceive, and needed more treatment cycles to get pregnant than patients in the traditional IVF program.

“LI-IVF appears to reduce pregnancy chances and prolongs time to conception without offering any appreciable compensatory financial benefits,” summarizes Norbert Gleicher, MD, the study’s lead author and medical director of CHR.

Dr. Gleicher adds that while CHR offers the procedure to patients, the center has always explained to patients that LI-IVF is experimental. “As the results of our study well demonstrate, doing otherwise would have been rather unethical.”

David Barad, MD, and co-author of the study added, “We must caution patients against resorting to ‘mini IVF’ or ‘natural IVF’ without carefully weighing their options. Until more data becomes available, physicians should offer LI-IVF only as an experimental procedure.”

Posted by admin

Dr. Gleicher questions Quebec’s single embryo transfer policy in Le Devoir

In a recent feature article, Le Devoir, a French-language Quebec newspaper, evaluated the effects of the 2010 legislation that placed strict restrictions on the number of embryos to be transferred in in vitro fertilization cycles. In the article, Dr. Gleicher provided a counter argument to many Quebec fertility specialists who praised the legislation for dramatically reducing the rate of multiple pregnancies down to single digits in the region.

Dr. Gleicher pointed out that the significant decrease in the IVF success rates is too costly for the possible benefits of reduced multiple pregnancy rates. Indeed, in Quebec, 43% of IVF treatments ended in a pregnancy in 2009. After the introduction of the strict SET policy, that number is now down to 29%.

For more information on CHR’s stance on balancing pregnancy rates and multiple birth risks in IVF cycles, please refer to our IVF and twins page.

Posted by admin